Thomas Cavanagh

Thomas is co-founder, CEO and a Board member of Oxular. An experienced ophthalmic pharmaceutical industry executive, Thomas has significant product development and transaction experience. He was formerly co-founder and CEO of Aciex Therapeutics, where he brought its lead program to NDA, oversaw the development of a novel API technology, which became the basis for future products, and led a successful M&A exit. His prior professional history includes positions as both a company officer and a consultant working in operational and advisory roles related to capital raises, M&A transactions, industry consolidations, strategic planning, debt financings, and post-merger integration. Thomas has an MBA from the Kellogg School of Management, Illinois, and a BSc from Binghamton University, New York.